Very early researchStudy completedNCT03276832
What this trial is testing
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Who this might be right for
Metastatic MelanomaStage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7+1 more
Mayo Clinic 7